ethinyl estradiol-norgestrel combination has been researched along with Precancerous Conditions in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hussain, SP; Rao, AR | 1 |
| Altmann, C; Wedig, MP | 1 |
| Black, WC; Bredfeldt, JE; Gyorffy, EJ | 1 |
3 other study(ies) available for ethinyl estradiol-norgestrel combination and Precancerous Conditions
| Article | Year |
|---|---|
Modulatory influence of oral contraceptive pills Ovral and Noracycline on 3-methylcholanthrene-induced carcinogenesis in the uterine cervix of mouse.
Topics: Animals; Body Weight; Carcinoma, Squamous Cell; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Lynestrenol; Mestranol; Methylcholanthrene; Mice; Norgestrel; Precancerous Conditions; Uterine Cervical Diseases; Uterine Cervical Neoplasms | 1992 |
[Hormonal contraception and focal nodular hyperplasia].
Topics: Adult; Carcinoma, Hepatocellular; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hyperplasia; Liver; Liver Neoplasms; Norgestrel; Precancerous Conditions; Risk Factors | 1991 |
Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use.
Topics: Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Liver Neoplasms; Middle Aged; Norgestrel; Precancerous Conditions | 1989 |